Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Mountain Valley MD Holdings Inc C.MVMD

Alternate Symbol(s):  MVMDF

Mountain Valley MD Holdings Inc. is a Canada-based biotech company, which is focused on advancing solutions to optimize human, animal, and plant health. The Company is focused on implementation, licensing and reselling of key technologies and formulations, such as Quicksome oral formulation and delivery technologies, Quicksol solubility formulation technology, and Agrarius, a novel agricultural plant signaling technology. Quicksome technology utilizes proprietary formulations and stabilizing molecules to encapsulate and formulate active ingredients into efficient product formats. Quicksol technology covers all solubilized macrocyclic lactones that could be applied in multiple viral applications that could impact human and animal health globally. Agrairus agricultural plant signaling technology is used as application to agricultural crops to naturally increase yields, reduce fertilizer usage, and enhance general resilience to pests and climate change.


CSE:MVMD - Post by User

Comment by Soccer Playeron Jun 27, 2022 10:52am
477 Views
Post# 34784472

RE:From Imminent in March 2021 to first quarter 2023 or beyond

RE:From Imminent in March 2021 to first quarter 2023 or beyondCould Dennis move any slower on everything they "SAY" is in process? I guess I forgot this company really only has 2 people and they work part time. I wonder if they didnt have cash if they would have more urgency to actually make something happen.

Ivermectin had alot of hype the past two years and that window of opportunity may have past because Dennis does not seem to know what to do to move projects forward.  This could be a very large company if they had someone who can make things happen instead of just creating alot of sizzle, no meat.

They have PR today but do not explain how this is going to help, what other applications they are going to apply it to, what other companies they could partner with or more importantly when they will see REVENUE from their patients. 
Makes you wonder if they really have anything worth while here as I can see Dennis is not the right guy to guide this medical product.
<< Previous
Bullboard Posts
Next >>